bluuebunny/crossref_metadata_2025 huggingface dataset:
Table S3 from Optimized EGFR Blockade Strategies in EGFR Addicted Gastroesophageal Adenocarcinomas
Authors: Corso Simona , Pietrantonio Filippo , Apicella Maria , Migliore Cristina , Conticelli Daniela , Petrelli Annalisa , D'Errico Laura , Durando Stefania , Moya-Rull Daniel , Bellomo Sara E. , Ughetto Stefano , Degiuli Maurizio , Reddavid Rossella , Fumagalli Uberto , De Pascale Stefano , Sgroi Giovanni , Rausa Emanuele , Baiocchi Gian Luca , Molfino Sarah , De Manzoni Giovanni , Bencivenga Maria , Siena Salvatore , Sartore-Bianchi Andrea , Morano Federica , Corallo Salvatore , Prisciandaro Michele , Di Bartolomeo Maria , Gloghini Annunziata , Marsoni Silvia , Sottile Antonino , Sapino Anna , Marchiò Caterina , Dahle-Smith Asa , Miedzybrodzka Zosia , Lee Jessica , Ali Siraj M. , Ross Jeffrey S. , Alexander Brian M. , Miller Vincent A. , Petty Russell , Schrock Alexa B. , Giordano Silvia
Published: April 2023

Supplementary Table 3
Supplementary Figure 12 from PGC1α-Mediated Metabolic Reprogramming Drives the Stemness of Pancreatic Precursor Lesions
Authors: Nimmakayala Rama Krishna , Rauth Sanchita , Chirravuri Venkata Ramakanth , Marimuthu Saravanakumar , Nallasamy Palanisamy , Vengoji Raghupathy , Lele Subodh M. , Rachagani Satyanarayana , Mallya Kavita , Malafa Mokenge P. , Ponnusamy Moorthy P. , Batra Surinder K.
Published: April 2023

SR18292 induces the acetylation of PGC1α in the indicated samples.
Figure S6 from Optimized EGFR Blockade Strategies in EGFR Addicted Gastroesophageal Adenocarcinomas
Authors: Corso Simona , Pietrantonio Filippo , Apicella Maria , Migliore Cristina , Conticelli Daniela , Petrelli Annalisa , D'Errico Laura , Durando Stefania , Moya-Rull Daniel , Bellomo Sara E. , Ughetto Stefano , Degiuli Maurizio , Reddavid Rossella , Fumagalli Uberto , De Pascale Stefano , Sgroi Giovanni , Rausa Emanuele , Baiocchi Gian Luca , Molfino Sarah , De Manzoni Giovanni , Bencivenga Maria , Siena Salvatore , Sartore-Bianchi Andrea , Morano Federica , Corallo Salvatore , Prisciandaro Michele , Di Bartolomeo Maria , Gloghini Annunziata , Marsoni Silvia , Sottile Antonino , Sapino Anna , Marchiò Caterina , Dahle-Smith Asa , Miedzybrodzka Zosia , Lee Jessica , Ali Siraj M. , Ross Jeffrey S. , Alexander Brian M. , Miller Vincent A. , Petty Russell , Schrock Alexa B. , Giordano Silvia
Published: April 2023

Supplementary Figure 6_Revised
Figure S5 from Optimized EGFR Blockade Strategies in EGFR Addicted Gastroesophageal Adenocarcinomas
Authors: Corso Simona , Pietrantonio Filippo , Apicella Maria , Migliore Cristina , Conticelli Daniela , Petrelli Annalisa , D'Errico Laura , Durando Stefania , Moya-Rull Daniel , Bellomo Sara E. , Ughetto Stefano , Degiuli Maurizio , Reddavid Rossella , Fumagalli Uberto , De Pascale Stefano , Sgroi Giovanni , Rausa Emanuele , Baiocchi Gian Luca , Molfino Sarah , De Manzoni Giovanni , Bencivenga Maria , Siena Salvatore , Sartore-Bianchi Andrea , Morano Federica , Corallo Salvatore , Prisciandaro Michele , Di Bartolomeo Maria , Gloghini Annunziata , Marsoni Silvia , Sottile Antonino , Sapino Anna , Marchiò Caterina , Dahle-Smith Asa , Miedzybrodzka Zosia , Lee Jessica , Ali Siraj M. , Ross Jeffrey S. , Alexander Brian M. , Miller Vincent A. , Petty Russell , Schrock Alexa B. , Giordano Silvia
Published: April 2023

Supplementary Figure 5
Figure S4 from Optimized EGFR Blockade Strategies in EGFR Addicted Gastroesophageal Adenocarcinomas
Authors: Corso Simona , Pietrantonio Filippo , Apicella Maria , Migliore Cristina , Conticelli Daniela , Petrelli Annalisa , D'Errico Laura , Durando Stefania , Moya-Rull Daniel , Bellomo Sara E. , Ughetto Stefano , Degiuli Maurizio , Reddavid Rossella , Fumagalli Uberto , De Pascale Stefano , Sgroi Giovanni , Rausa Emanuele , Baiocchi Gian Luca , Molfino Sarah , De Manzoni Giovanni , Bencivenga Maria , Siena Salvatore , Sartore-Bianchi Andrea , Morano Federica , Corallo Salvatore , Prisciandaro Michele , Di Bartolomeo Maria , Gloghini Annunziata , Marsoni Silvia , Sottile Antonino , Sapino Anna , Marchiò Caterina , Dahle-Smith Asa , Miedzybrodzka Zosia , Lee Jessica , Ali Siraj M. , Ross Jeffrey S. , Alexander Brian M. , Miller Vincent A. , Petty Russell , Schrock Alexa B. , Giordano Silvia
Published: April 2023

Supplementary Figure 4_Revised
Figure S2 from Optimized EGFR Blockade Strategies in EGFR Addicted Gastroesophageal Adenocarcinomas
Authors: Corso Simona , Pietrantonio Filippo , Apicella Maria , Migliore Cristina , Conticelli Daniela , Petrelli Annalisa , D'Errico Laura , Durando Stefania , Moya-Rull Daniel , Bellomo Sara E. , Ughetto Stefano , Degiuli Maurizio , Reddavid Rossella , Fumagalli Uberto , De Pascale Stefano , Sgroi Giovanni , Rausa Emanuele , Baiocchi Gian Luca , Molfino Sarah , De Manzoni Giovanni , Bencivenga Maria , Siena Salvatore , Sartore-Bianchi Andrea , Morano Federica , Corallo Salvatore , Prisciandaro Michele , Di Bartolomeo Maria , Gloghini Annunziata , Marsoni Silvia , Sottile Antonino , Sapino Anna , Marchiò Caterina , Dahle-Smith Asa , Miedzybrodzka Zosia , Lee Jessica , Ali Siraj M. , Ross Jeffrey S. , Alexander Brian M. , Miller Vincent A. , Petty Russell , Schrock Alexa B. , Giordano Silvia
Published: April 2023

Supplementary Figure 2
Supplementary Data from Myeloid Cell–associated Resistance to PD-1/PD-L1 Blockade in Urothelial Cancer Revealed Through Bulk and Single-cell RNA Sequencing
Authors: Wang Li , Sfakianos John P. , Beaumont Kristin G. , Akturk Guray , Horowitz Amir , Sebra Robert P. , Farkas Adam M. , Gnjatic Sacha , Hake Austin , Izadmehr Sudeh , Wiklund Peter , Oh William K. , Szabo Peter M. , Wind-Rotolo Megan , Unsal-Kacmaz Keziban , Yao Xin , Schadt Eric , Sharma Padmanee , Bhardwaj Nina , Zhu Jun , Galsky Matthew D.
Published: April 2023

Supplementary Data from Myeloid Cell–associated Resistance to PD-1/PD-L1 Blockade in Urothelial Cancer Revealed Through Bulk and Single-cell RNA Sequencing
Table S2 from Impact of Prior Treatment on the Efficacy of Adoptive Transfer of Tumor-Infiltrating Lymphocytes in Patients with Metastatic Melanoma
Authors: Seitter Samantha J. , Sherry Richard M. , Yang James C. , Robbins Paul F. , Shindorf Mackenzie L. , Copeland Amy R. , McGowan Christine T. , Epstein Monica , Shelton Thomas E. , Langhan Michelle M. , Franco Zulmarie , Danforth David N. , White Donald E. , Rosenberg Steven A. , Goff Stephanie L.
Published: April 2023

Table S2 describes treatment characteristics by clinical response to treatment
Figure S2 from Impact of Prior Treatment on the Efficacy of Adoptive Transfer of Tumor-Infiltrating Lymphocytes in Patients with Metastatic Melanoma
Authors: Seitter Samantha J. , Sherry Richard M. , Yang James C. , Robbins Paul F. , Shindorf Mackenzie L. , Copeland Amy R. , McGowan Christine T. , Epstein Monica , Shelton Thomas E. , Langhan Michelle M. , Franco Zulmarie , Danforth David N. , White Donald E. , Rosenberg Steven A. , Goff Stephanie L.
Published: April 2023

Post ACT survival (MSS and PFS) data for patients with BRAF V600E/K (+) tumors with respect to prior therapy
Supplementary Data from Double-hit Signature with TP53 Abnormalities Predicts Poor Survival in Patients with Germinal Center Type Diffuse Large B-cell Lymphoma Treated with R-CHOP
Authors: Song Joo Y. , Perry Anamarija M. , Herrera Alex F. , Chen Lu , Skrabek Pamela , Nasr Michel R. , Ottesen Rebecca A. , Nikowitz Janet , Bedell Victoria , Murata-Collins Joyce , Li Yuping , McCarthy Christine , Pillai Raju , Wang Jinhui , Wu Xiwei , Zain Jasmine , Popplewell Leslie , Kwak Larry W. , Nademanee Auayporn P. , Niland Joyce C. , Scott David W. , Gong Qiang , Chan Wing C. , Weisenburger Dennis D.
Published: April 2023

Supplemental Material
Supplementary Data from Heterogeneity of IFN-Mediated Responses and Tumor Immunogenicity in Patients with Cervical Cancer Receiving Concurrent Chemoradiotherapy
Authors: Chen Jianzhou , Chen Chuangzhen , Zhan Yizhou , Zhou Li , Chen Jie , Cai Qingxin , Wu Yanxuan , Sui Zhihan , Zeng Chengbing , Wei Xiaolong , Muschel Ruth
Published: April 2023

Figure S1-S14
Table S5 from Copy Number Aberration Analysis to Predict Response to Neoadjuvant Anti-HER2 Therapy: Results from the NeoALTTO Phase III Clinical Trial
Authors: Venet David , Rediti Mattia , Maetens Marion , Fumagalli Debora , Brown David N. , Majjaj Samira , Salgado Roberto , Pusztai Lajos , Harbeck Nadia , El-Abed Sarra , Wang Yingbo , Saura Cristina , Gomez Henry , Semiglazov Vladimir Fedorovich , de Azambuja Evandro , Huober Jens , Nuciforo Paolo , Di Cosimo Serena , Piccart Martine , Loi Sherene , Rothé Françoise , Sotiriou Christos
Published: April 2023

Table S5: Genes in the chr6q23-24 region, association with CN levels and pCR.
Table S1, S2, S3, S4 from Copy Number Aberration Analysis to Predict Response to Neoadjuvant Anti-HER2 Therapy: Results from the NeoALTTO Phase III Clinical Trial
Authors: Venet David , Rediti Mattia , Maetens Marion , Fumagalli Debora , Brown David N. , Majjaj Samira , Salgado Roberto , Pusztai Lajos , Harbeck Nadia , El-Abed Sarra , Wang Yingbo , Saura Cristina , Gomez Henry , Semiglazov Vladimir Fedorovich , de Azambuja Evandro , Huober Jens , Nuciforo Paolo , Di Cosimo Serena , Piccart Martine , Loi Sherene , Rothé Françoise , Sotiriou Christos
Published: April 2023

Table S1: Clinicopathological characteristics of the patients. Table S2: List of 49 genes associated with CNAs in breast cancer from the COSMIC Cancer Gene Census database. Table S3: Gene ontology analysis of the genes correlated with the genome instability index. Table S4: Gene ontology analysis of the genes anti-correlated with the genome instability index.
Supplementary Figure S7 from Evolution of Castration-Resistant Prostate Cancer in ctDNA during Sequential Androgen Receptor Pathway Inhibition
Authors: Annala Matti , Taavitsainen Sinja , Khalaf Daniel J. , Vandekerkhove Gillian , Beja Kevin , Sipola Joonatan , Warner Evan W. , Herberts Cameron , Wong Amanda , Fu Simon , Finch Daygen L. , Oja Conrad D. , Vergidis Joanna , Zulfiqar Muhammad , Eigl Bernhard J. , Kollmansberger Christian K. , Nykter Matti , Gleave Martin E. , Chi Kim N. , Wyatt Alexander W.
Published: April 2023

Supplementary Figure S7 shows the concordance of gene coverage logratios between 72-gene targeted sequencing and whole exome sequencing
Supplementary Figure S6 from Evolution of Castration-Resistant Prostate Cancer in ctDNA during Sequential Androgen Receptor Pathway Inhibition
Authors: Annala Matti , Taavitsainen Sinja , Khalaf Daniel J. , Vandekerkhove Gillian , Beja Kevin , Sipola Joonatan , Warner Evan W. , Herberts Cameron , Wong Amanda , Fu Simon , Finch Daygen L. , Oja Conrad D. , Vergidis Joanna , Zulfiqar Muhammad , Eigl Bernhard J. , Kollmansberger Christian K. , Nykter Matti , Gleave Martin E. , Chi Kim N. , Wyatt Alexander W.
Published: April 2023

Supplementary Figure S6 shows that circulating tumor DNA fraction correlates with patient tumor burden.
Supplementary Figure 4 from Phase I Trial of DNA Methyltransferase Inhibitor Guadecitabine Combined with Cisplatin and Gemcitabine for Solid Malignancies Including Urothelial Carcinoma (SPIRE)
Authors: Crabb Simon J. , Danson Sarah , Catto James W.F. , Hussain Syed , Chan Danna , Dunkley Denise , Downs Nichola , Marwood Ellice , Day Laura , Saunders Geoff , Light Michelle , Whitehead Amy , Ellis Deborah , Sarwar Naveed , Enting Deborah , Birtle Alison , Johnson Bernadette , Huddart Robert , Griffiths Gareth
Published: April 2023

Supplementary Figure 4 shows pharmacokinetic parameters for guadecitabine and decitabine in the dose escalation phase
Supplementary Figure S24 from Evolution of Castration-Resistant Prostate Cancer in ctDNA during Sequential Androgen Receptor Pathway Inhibition
Authors: Annala Matti , Taavitsainen Sinja , Khalaf Daniel J. , Vandekerkhove Gillian , Beja Kevin , Sipola Joonatan , Warner Evan W. , Herberts Cameron , Wong Amanda , Fu Simon , Finch Daygen L. , Oja Conrad D. , Vergidis Joanna , Zulfiqar Muhammad , Eigl Bernhard J. , Kollmansberger Christian K. , Nykter Matti , Gleave Martin E. , Chi Kim N. , Wyatt Alexander W.
Published: April 2023

Supplementary Figure S24 shows that amplification of the enhancer region 640 kb upstream of the androgen receptor (AR) is common.
Supplementary Figure S23 from Evolution of Castration-Resistant Prostate Cancer in ctDNA during Sequential Androgen Receptor Pathway Inhibition
Authors: Annala Matti , Taavitsainen Sinja , Khalaf Daniel J. , Vandekerkhove Gillian , Beja Kevin , Sipola Joonatan , Warner Evan W. , Herberts Cameron , Wong Amanda , Fu Simon , Finch Daygen L. , Oja Conrad D. , Vergidis Joanna , Zulfiqar Muhammad , Eigl Bernhard J. , Kollmansberger Christian K. , Nykter Matti , Gleave Martin E. , Chi Kim N. , Wyatt Alexander W.
Published: April 2023

Supplementary Figure S23 provides AR region copy number profiles for all 20 patients that showed a change in the structure of androgen receptor (AR) amplifications after treatment with abiraterone/enzalutamide
Supplementary Figure 6 from FLT3L Release by Natural Killer Cells Enhances Response to Radioimmunotherapy in Preclinical Models of HNSCC
Authors: Bickett Thomas E. , Knitz Michael , Darragh Laurel B. , Bhatia Shilpa , Van Court Benjamin , Gadwa Jacob , Bhuvane Shiv , Piper Miles , Nguyen Diemmy , Tu Hua , Lenz Laurel , Clambey Eric T. , Barry Kevin , Karam Sana D.
Published: April 2023

Supplementary Figure 6 (A) Survival curve comparing patients with high expression of FLT3, the FLT3LG receptor, to patients with low expression of FLT3 expression. (B) Survival curve comparing patients with high expression of FLT3LG to patients with low expression of FLT3LG.
Supplementary Figure 5 from FLT3L Release by Natural Killer Cells Enhances Response to Radioimmunotherapy in Preclinical Models of HNSCC
Authors: Bickett Thomas E. , Knitz Michael , Darragh Laurel B. , Bhatia Shilpa , Van Court Benjamin , Gadwa Jacob , Bhuvane Shiv , Piper Miles , Nguyen Diemmy , Tu Hua , Lenz Laurel , Clambey Eric T. , Barry Kevin , Karam Sana D.
Published: April 2023

Supplementary Figure 5 (A) IL-15 amounts in serum of Balb/c mice treated with RT, anti-CD25, anti-asialoGM1 to deplete NK cells, and FLT3L; **** p{less than or equal to}0.0001; n=6. (B) Flow cytometric analysis of DCs MOC2 tumors after treatment with radiation therapy and anti-CD25; n=5. (C) growth curves of MOC2 tumors in individual mice treated with radiation therapy, anti-CD25, and anti-CD137.
Supplementary Figure 3 from FLT3L Release by Natural Killer Cells Enhances Response to Radioimmunotherapy in Preclinical Models of HNSCC
Authors: Bickett Thomas E. , Knitz Michael , Darragh Laurel B. , Bhatia Shilpa , Van Court Benjamin , Gadwa Jacob , Bhuvane Shiv , Piper Miles , Nguyen Diemmy , Tu Hua , Lenz Laurel , Clambey Eric T. , Barry Kevin , Karam Sana D.
Published: April 2023

Supplementary Figure 3 (A) MOC2 tumor volumes of mice treated with RT, anti-CD25, and pLEV vehicle control (black line); RT, anti-CD25, and pLEV FLT3L plasmid (green line), and RT + anti-CD25 (red line). n=7. (B) Flow Cytometry analysis of CD8 T cell populations in MOC2 tumors and lymph nodes (LN) of C57 BL/6 mice. MOC2 tumors were harvested 3 days after RT, NK cell depletion and FLT3L therapy; n=6.
Supplementary Figure S13 from Evolution of Castration-Resistant Prostate Cancer in ctDNA during Sequential Androgen Receptor Pathway Inhibition
Authors: Annala Matti , Taavitsainen Sinja , Khalaf Daniel J. , Vandekerkhove Gillian , Beja Kevin , Sipola Joonatan , Warner Evan W. , Herberts Cameron , Wong Amanda , Fu Simon , Finch Daygen L. , Oja Conrad D. , Vergidis Joanna , Zulfiqar Muhammad , Eigl Bernhard J. , Kollmansberger Christian K. , Nykter Matti , Gleave Martin E. , Chi Kim N. , Wyatt Alexander W.
Published: April 2023

Supplementary Figure S13 shows temporal changes in copy number profiles detected via 72-gene targeted sequencing
Table S2 from Sex-Based Dimorphism of Anticancer Immune Response and Molecular Mechanisms of Immune Evasion
Authors: Conforti Fabio , Pala Laura , Pagan Eleonora , Bagnardi Vincenzo , De Pas Tommaso , Queirolo Paola , Pennacchioli Elisabetta , Catania Chiara , Cocorocchio Emilia , Ferrucci Pier Francesco , Saponara Maristella , Orsolini Gianmarco , Zagami Paola , Nicoló Eleonora , De Marinis Filippo , Tortora Giampaolo , Bria Emilio , Minucci Saverio , Joffe Hadine , Veronesi Paolo , Wargo Jennifer , Rosenthal Rachel , Swanton Charles , Mantovani Alberto , Gelber Richard D. , Viale Giuseppe , Goldhirsch Aron , Giaccone Giuseppe
Published: April 2023

Supplementary Table S2
Legends of supplementary figure 1 and 2 from Sex-Based Dimorphism of Anticancer Immune Response and Molecular Mechanisms of Immune Evasion
Authors: Conforti Fabio , Pala Laura , Pagan Eleonora , Bagnardi Vincenzo , De Pas Tommaso , Queirolo Paola , Pennacchioli Elisabetta , Catania Chiara , Cocorocchio Emilia , Ferrucci Pier Francesco , Saponara Maristella , Orsolini Gianmarco , Zagami Paola , Nicoló Eleonora , De Marinis Filippo , Tortora Giampaolo , Bria Emilio , Minucci Saverio , Joffe Hadine , Veronesi Paolo , Wargo Jennifer , Rosenthal Rachel , Swanton Charles , Mantovani Alberto , Gelber Richard D. , Viale Giuseppe , Goldhirsch Aron , Giaccone Giuseppe
Published: April 2023

Legends of supplementary figure S1 and S2
Figure S1-S8 from Abiraterone Acetate Induces CREB1 Phosphorylation and Enhances the Function of the CBP-p300 Complex, Leading to Resistance in Prostate Cancer Cells
Authors: Pan Wenting , Zhang Zhouwei , Kimball Hannah , Qu Fangfang , Berlind Kyler , Stopsack Konrad H. , Lee Gwo-Shu Mary , Choueiri Toni K. , Kantoff Philip W.
Published: April 2023

Figure S1-S8
Supplementary Table-S5 from EpiPanGI Dx: A Cell-free DNA Methylation Fingerprint for the Early Detection of Gastrointestinal Cancers
Authors: Kandimalla Raju , Xu Jianfeng , Link Alexander , Matsuyama Takatoshi , Yamamura Kensuke , Parker M. Iqbal , Uetake Hiroyuki , Balaguer Francesc , Borazanci Erkut , Tsai Susan , Evans Douglas , Meltzer Stephen J. , Baba Hideo , Brand Randall , Von Hoff Daniel , Li Wei , Goel Ajay
Published: April 2023

Supplementary Table-S5
Supplementary Table-S4 from EpiPanGI Dx: A Cell-free DNA Methylation Fingerprint for the Early Detection of Gastrointestinal Cancers
Authors: Kandimalla Raju , Xu Jianfeng , Link Alexander , Matsuyama Takatoshi , Yamamura Kensuke , Parker M. Iqbal , Uetake Hiroyuki , Balaguer Francesc , Borazanci Erkut , Tsai Susan , Evans Douglas , Meltzer Stephen J. , Baba Hideo , Brand Randall , Von Hoff Daniel , Li Wei , Goel Ajay
Published: April 2023

Supplementary Table-S4
Supplementary Data from Phase I Study of Zotiraciclib in Combination with Temozolomide for Patients with Recurrent High-grade Astrocytomas
Authors: Wu Jing , Yuan Ying , Long Priel Debra A. , Fink Danielle , Peer Cody J. , Sissung Tristan M. , Su Yu-Ting , Pang Ying , Yu Guangyang , Butler Madison K. , Mendoza Tito R. , Vera Elizabeth , Ahmad Salman , Bryla Christine , Lindsley Matthew , Grajkowska Ewa , Mentges Kelly , Boris Lisa , Antony Ramya , Garren Nancy , Siegel Christine , Lollo Nicole , Cordova Christine , Aboud Orwa , Theeler Brett J. , Burton Eric M. , Penas-Prado Marta , Leeper Heather , Gonzales Javier , Armstrong Terri S. , Calvo Katherine R. , Figg William D. , Kuhns Douglas B. , Gallin John I. , Gilbert Mark R.
Published: April 2023

Supplementary Figures and Tables
Supplementary Table-S3 from EpiPanGI Dx: A Cell-free DNA Methylation Fingerprint for the Early Detection of Gastrointestinal Cancers
Authors: Kandimalla Raju , Xu Jianfeng , Link Alexander , Matsuyama Takatoshi , Yamamura Kensuke , Parker M. Iqbal , Uetake Hiroyuki , Balaguer Francesc , Borazanci Erkut , Tsai Susan , Evans Douglas , Meltzer Stephen J. , Baba Hideo , Brand Randall , Von Hoff Daniel , Li Wei , Goel Ajay
Published: April 2023

Supplementary Table-S3
Supplementary Fig. 9 from EpiPanGI Dx: A Cell-free DNA Methylation Fingerprint for the Early Detection of Gastrointestinal Cancers
Authors: Kandimalla Raju , Xu Jianfeng , Link Alexander , Matsuyama Takatoshi , Yamamura Kensuke , Parker M. Iqbal , Uetake Hiroyuki , Balaguer Francesc , Borazanci Erkut , Tsai Susan , Evans Douglas , Meltzer Stephen J. , Baba Hideo , Brand Randall , Von Hoff Daniel , Li Wei , Goel Ajay
Published: April 2023

Hierarchical clustering of PDAC and healthy plasma samples
Supplementary Fig. 5 from EpiPanGI Dx: A Cell-free DNA Methylation Fingerprint for the Early Detection of Gastrointestinal Cancers
Authors: Kandimalla Raju , Xu Jianfeng , Link Alexander , Matsuyama Takatoshi , Yamamura Kensuke , Parker M. Iqbal , Uetake Hiroyuki , Balaguer Francesc , Borazanci Erkut , Tsai Susan , Evans Douglas , Meltzer Stephen J. , Baba Hideo , Brand Randall , Von Hoff Daniel , Li Wei , Goel Ajay
Published: April 2023

Hierarchical clustering of HCC and healthy plasma samples
Supplementary Fig. 2 from EpiPanGI Dx: A Cell-free DNA Methylation Fingerprint for the Early Detection of Gastrointestinal Cancers
Authors: Kandimalla Raju , Xu Jianfeng , Link Alexander , Matsuyama Takatoshi , Yamamura Kensuke , Parker M. Iqbal , Uetake Hiroyuki , Balaguer Francesc , Borazanci Erkut , Tsai Susan , Evans Douglas , Meltzer Stephen J. , Baba Hideo , Brand Randall , Von Hoff Daniel , Li Wei , Goel Ajay
Published: April 2023

Methylation ratio distribution of the gitBS performed on normal plasma samples (a) and GI cancer plasma samples (b).
Supplementary Fig. 17 from EpiPanGI Dx: A Cell-free DNA Methylation Fingerprint for the Early Detection of Gastrointestinal Cancers
Authors: Kandimalla Raju , Xu Jianfeng , Link Alexander , Matsuyama Takatoshi , Yamamura Kensuke , Parker M. Iqbal , Uetake Hiroyuki , Balaguer Francesc , Borazanci Erkut , Tsai Susan , Evans Douglas , Meltzer Stephen J. , Baba Hideo , Brand Randall , Von Hoff Daniel , Li Wei , Goel Ajay
Published: April 2023

Pan-GI prediction accuracy using various number of DMRs identified from pan-GI vs. healthy plasma sample analysis
Supplementary Fig. 1 from EpiPanGI Dx: A Cell-free DNA Methylation Fingerprint for the Early Detection of Gastrointestinal Cancers
Authors: Kandimalla Raju , Xu Jianfeng , Link Alexander , Matsuyama Takatoshi , Yamamura Kensuke , Parker M. Iqbal , Uetake Hiroyuki , Balaguer Francesc , Borazanci Erkut , Tsai Susan , Evans Douglas , Meltzer Stephen J. , Baba Hideo , Brand Randall , Von Hoff Daniel , Li Wei , Goel Ajay
Published: April 2023

Coverage distribution of the gitBS performed on 300 plasma samples
Supplementary Data from Phase I Dose-Escalation Trial of MIW815 (ADU-S100), an Intratumoral STING Agonist, in Patients with Advanced/Metastatic Solid Tumors or Lymphomas
Authors: Meric-Bernstam Funda , Sweis Randy F. , Hodi F. Stephen , Messersmith Wells A. , Andtbacka Robert H.I. , Ingham Matthew , Lewis Nancy , Chen Xinhui , Pelletier Marc , Chen Xueying , Wu Jincheng , McWhirter Sarah M. , Müller Thomas , Nair Nitya , Luke Jason J.
Published: April 2023

Supplementary Data from Phase I Dose-Escalation Trial of MIW815 (ADU-S100), an Intratumoral STING Agonist, in Patients with Advanced/Metastatic Solid Tumors or Lymphomas
Supplementary Figure from Bone Marrow Surveillance of Pediatric Cancer Survivors Identifies Clones that Predict Therapy-Related Leukemia
Authors: Spitzer Barbara , Rutherford Kayleigh D. , Gundem Gunes , McGovern Erin M. , Millard Nathan E. , Arango Ossa Juan E. , Cheung Irene Y. , Gao Teng , Levine Max F. , Zhang Yanming , Medina-Martínez Juan S. , Feng Yi , Ptashkin Ryan N. , Bolton Kelly L. , Farnoud Noushin , Zhou Yangyu , Patel Minal A. , Asimomitis Georgios , Cobbs Cassidy C. , Mohibullah Neeman , Huberman Kety H. , Arcilla Maria E. , Kushner Brian H. , Modak Shakeel , Kung Andrew L. , Zehir Ahmet , Levine Ross L. , Armstrong Scott A. , Cheung Nai Kong V. , Papaemmanuil Elli
Published: April 2023

Supplementary Figure from Bone Marrow Surveillance of Pediatric Cancer Survivors Identifies Clones that Predict Therapy-Related Leukemia
Supplementary Figure 1 from Association of PD-1/PD-L1 Co-location with Immunotherapy Outcomes in Non–Small Cell Lung Cancer
Authors: Gavrielatou Niki , Liu Yuting , Vathiotis Ioannis , Zugazagoitia Jon , Aung Thazin Nwe , Shafi Saba , Fernandez Aileen , Schalper Kurt , Psyrri Amanda , Rimm David L.
Published: April 2023

Supplemental Figure 1. Multivariate analysis of co-location score, age, gender smoking and histologic subtype association with PFS and OS in total cohort population A-B and in >1st line of treatment subgroup C-D. (Cox PH: Cox proportional hazards model)
Supplementary Table from Somatic and Germline Genomic Alterations in Very Young Women with Breast Cancer
Authors: Waks Adrienne G. , Kim Dewey , Jain Esha , Snow Craig , Kirkner Gregory J. , Rosenberg Shoshana M. , Oh Coyin , Poorvu Philip D. , Ruddy Kathryn J. , Tamimi Rulla M. , Peppercorn Jeffrey , Schapira Lidia , Borges Virginia F. , Come Steven E. , Brachtel Elena F. , Warner Ellen , Collins Laura C. , Partridge Ann H. , Wagle Nikhil
Published: April 2023

Supplementary Table from Somatic and Germline Genomic Alterations in Very Young Women with Breast Cancer
Table S2 from A Uniform Computational Approach Improved on Existing Pipelines to Reveal Microbiome Biomarkers of Nonresponse to Immune Checkpoint Inhibitors
Authors: Shaikh Fyza Y. , White James R. , Gills Joell J. , Hakozaki Taiki , Richard Corentin , Routy Bertrand , Okuma Yusuke , Usyk Mykhaylo , Pandey Abhishek , Weber Jeffrey S. , Ahn Jiyoung , Lipson Evan J. , Naidoo Jarushka , Pardoll Drew M. , Sears Cynthia L.
Published: April 2023

Table S2
Table S1 from A Uniform Computational Approach Improved on Existing Pipelines to Reveal Microbiome Biomarkers of Nonresponse to Immune Checkpoint Inhibitors
Authors: Shaikh Fyza Y. , White James R. , Gills Joell J. , Hakozaki Taiki , Richard Corentin , Routy Bertrand , Okuma Yusuke , Usyk Mykhaylo , Pandey Abhishek , Weber Jeffrey S. , Ahn Jiyoung , Lipson Evan J. , Naidoo Jarushka , Pardoll Drew M. , Sears Cynthia L.
Published: April 2023

Table S1
eMethods from Circulating Protein Biomarkers for Use in Pancreatic Ductal Adenocarcinoma Identification
Authors: Lindgaard Sidsel C. , Sztupinszki Zsófia , Maag Emil , Chen Inna M. , Johansen Astrid Z. , Jensen Benny V. , Bojesen Stig E. , Nielsen Dorte L. , Hansen Carsten P. , Hasselby Jane P. , Nielsen Kaspar R. , Szallasi Zoltan , Johansen Julia S.
Published: April 2023

eMethods include extra details on the Olink analyses, the statistical analyses, the PubMed search for related articles, as well as REMARK and TRIPOD checklists.
Figure S4 from A Uniform Computational Approach Improved on Existing Pipelines to Reveal Microbiome Biomarkers of Nonresponse to Immune Checkpoint Inhibitors
Authors: Shaikh Fyza Y. , White James R. , Gills Joell J. , Hakozaki Taiki , Richard Corentin , Routy Bertrand , Okuma Yusuke , Usyk Mykhaylo , Pandey Abhishek , Weber Jeffrey S. , Ahn Jiyoung , Lipson Evan J. , Naidoo Jarushka , Pardoll Drew M. , Sears Cynthia L.
Published: April 2023

Figure S4: Sensitivity and specificity analysis of the Integrated Microbiome Prediction Index for response prediction in responder (R) vs nonresponder (NR), further stratified by inclusion (+) or exclusion (-) of stable disease (SD) if available.
Figure S3 from A Uniform Computational Approach Improved on Existing Pipelines to Reveal Microbiome Biomarkers of Nonresponse to Immune Checkpoint Inhibitors
Authors: Shaikh Fyza Y. , White James R. , Gills Joell J. , Hakozaki Taiki , Richard Corentin , Routy Bertrand , Okuma Yusuke , Usyk Mykhaylo , Pandey Abhishek , Weber Jeffrey S. , Ahn Jiyoung , Lipson Evan J. , Naidoo Jarushka , Pardoll Drew M. , Sears Cynthia L.
Published: April 2023

Figure S3. Complete species list for each index identified through re-analysis of raw sequencing data or as reported by the authors.
Figure S3 from Circulating Protein Biomarkers for Use in Pancreatic Ductal Adenocarcinoma Identification
Authors: Lindgaard Sidsel C. , Sztupinszki Zsófia , Maag Emil , Chen Inna M. , Johansen Astrid Z. , Jensen Benny V. , Bojesen Stig E. , Nielsen Dorte L. , Hansen Carsten P. , Hasselby Jane P. , Nielsen Kaspar R. , Szallasi Zoltan , Johansen Julia S.
Published: April 2023

Supplementary figure S3 shows an illustration of proteins in Index II with weight contributing to the model
Supplementary Data from Induction of Synthetic Lethality by Activation of Mitochondrial ClpP and Inhibition of HDAC1/2 in Glioblastoma
Authors: Nguyen Trang T.T. , Shang Enyuan , Schiffgens Salveena , Torrini Consuelo , Shu Chang , Akman Hasan Orhan , Prabhu Varun V. , Allen Joshua E. , Westhoff Mike-Andrew , Karpel-Massler Georg , Siegelin Markus D.
Published: April 2023

Supplementary Data from Induction of Synthetic Lethality by Activation of Mitochondrial ClpP and Inhibition of HDAC1/2 in Glioblastoma
Supplementary Table from The PD-L1/4-1BB Bispecific Antibody–Anticalin Fusion Protein PRS-344/S095012 Elicits Strong T-Cell Stimulation in a Tumor-Localized Manner
Authors: Peper-Gabriel Janet K. , Pavlidou Marina , Pattarini Lucia , Morales-Kastresana Aizea , Jaquin Thomas J. , Gallou Catherine , Hansbauer Eva-Maria , Richter Marleen , Lelievre Helene , Scholer-Dahirel Alix , Bossenmaier Birgit , Sancerne Celine , Riviere Matthieu , Grandclaudon Maximilien , Zettl Markus , Bel Aiba Rachida S. , Rothe Christine , Blanc Veronique , Olwill Shane A.
Published: April 2023

Supplementary Table from The PD-L1/4-1BB Bispecific Antibody–Anticalin Fusion Protein PRS-344/S095012 Elicits Strong T-Cell Stimulation in a Tumor-Localized Manner
Supplementary Table from A Phase 1a/b Open-Label, Dose-Escalation Study of Etigilimab Alone or in Combination with Nivolumab in Patients with Locally Advanced or Metastatic Solid Tumors
Authors: Mettu Niharika B. , Ulahannan Susanna V. , Bendell Johanna C. , Garrido-Laguna Ignacio , Strickler John H. , Moore Kathleen N. , Stagg Robert , Kapoun Ann M. , Faoro Leonardo , Sharma Sunil
Published: April 2023

Supplementary Table from A Phase 1a/b Open-Label, Dose-Escalation Study of Etigilimab Alone or in Combination with Nivolumab in Patients with Locally Advanced or Metastatic Solid Tumors
Supplementary Figure from The PD-L1/4-1BB Bispecific Antibody–Anticalin Fusion Protein PRS-344/S095012 Elicits Strong T-Cell Stimulation in a Tumor-Localized Manner
Authors: Peper-Gabriel Janet K. , Pavlidou Marina , Pattarini Lucia , Morales-Kastresana Aizea , Jaquin Thomas J. , Gallou Catherine , Hansbauer Eva-Maria , Richter Marleen , Lelievre Helene , Scholer-Dahirel Alix , Bossenmaier Birgit , Sancerne Celine , Riviere Matthieu , Grandclaudon Maximilien , Zettl Markus , Bel Aiba Rachida S. , Rothe Christine , Blanc Veronique , Olwill Shane A.
Published: April 2023

Supplementary Figure from The PD-L1/4-1BB Bispecific Antibody–Anticalin Fusion Protein PRS-344/S095012 Elicits Strong T-Cell Stimulation in a Tumor-Localized Manner
Supplementary Figure from A Phase 1a/b Open-Label, Dose-Escalation Study of Etigilimab Alone or in Combination with Nivolumab in Patients with Locally Advanced or Metastatic Solid Tumors
Authors: Mettu Niharika B. , Ulahannan Susanna V. , Bendell Johanna C. , Garrido-Laguna Ignacio , Strickler John H. , Moore Kathleen N. , Stagg Robert , Kapoun Ann M. , Faoro Leonardo , Sharma Sunil
Published: April 2023

Supplementary Figure from A Phase 1a/b Open-Label, Dose-Escalation Study of Etigilimab Alone or in Combination with Nivolumab in Patients with Locally Advanced or Metastatic Solid Tumors
Supplementary Table 1 from A Multicenter Phase II Trial of Ipilimumab and Nivolumab in Unresectable or Metastatic Metaplastic Breast Cancer: Cohort 36 of Dual Anti–CTLA-4 and Anti–PD-1 Blockade in Rare Tumors (DART, SWOG S1609)
Authors: Adams Sylvia , Othus Megan , Patel Sandip Pravin , Miller Kathy D. , Chugh Rashmi , Schuetze Scott M. , Chamberlin Mary D. , Haley Barbara J. , Storniolo Anna Maria V. , Reddy Mridula P. , Anderson Scott A. , Zimmerman Collin T. , O'Dea Anne P. , Mirshahidi Hamid R. , Ahnert Jordi Rodon , Brescia Frank J. , Hahn Olwen , Raymond Jane M. , Biggs David D. , Connolly Roisin M. , Sharon Elad , Korde Larissa A. , Gray Robert J. , Mayerson Edward , Plets Melissa , Blanke Charles D. , Chae Young Kwang , Kurzrock Razelle
Published: April 2023

Supplemental Table 1: Clinical and tumor characteristics of long-term responders
Table S3 from A PD-1/PD-L1 Proximity Assay as a Theranostic Marker for PD-1 Blockade in Patients with Metastatic Melanoma
Authors: Girault Isabelle , Adam Julien , Shen Shensi , Roy Séverine , Brard Caroline , Faouzi Sara , Routier Emilie , Lupu Jéremy , Warren Sarah , Sorg Kristina , Ong SuFey , Morel Pascale , Scoazec Jean-Yves , Vagner Stéphan , Robert Caroline
Published: April 2023

Association between PLA score, disease characteristics and prior treatments
Supplementary Data from A Phase I and Surgical Study of Ribociclib and Everolimus in Children with Recurrent or Refractory Malignant Brain Tumors: A Pediatric Brain Tumor Consortium Study
Authors: DeWire Mariko D. , Fuller Christine , Campagne Olivia , Lin Tong , Pan Haitao , Young Poussaint Tina , Baxter Patricia A. , Hwang Eugene I. , Bukowinski Andrew , Dorris Kathleen , Hoffman Lindsey , Waanders Angela J. , Karajannis Matthias A. , Stewart Clinton F. , Onar-Thomas Arzu , Fouladi Maryam , Dunkel Ira J.
Published: April 2023

Pharmacokinetic Data Analysis
Supplementary Table 3 from Mucin Expression and Splicing Determine Novel Subtypes and Patient Mortality in Pancreatic Ductal Adenocarcinoma
Authors: Thompson Christopher M. , Cannon Andrew , West Sean , Ghersi Dario , Atri Pranita , Bhatia Rakesh , Smith Lynette , Rachagani Satyayanarayana , Wichman Christopher , Kumar Sushil , Batra Surinder K.
Published: April 2023

Kruskal-Wallis test of mucin expression between normal, PDAC samples, and high vs. low cellularity samples
Supplementary Legends from Mucin Expression and Splicing Determine Novel Subtypes and Patient Mortality in Pancreatic Ductal Adenocarcinoma
Authors: Thompson Christopher M. , Cannon Andrew , West Sean , Ghersi Dario , Atri Pranita , Bhatia Rakesh , Smith Lynette , Rachagani Satyayanarayana , Wichman Christopher , Kumar Sushil , Batra Surinder K.
Published: April 2023

Supplementary Figure/Table legends
Figure S2 from Mucin Expression and Splicing Determine Novel Subtypes and Patient Mortality in Pancreatic Ductal Adenocarcinoma
Authors: Thompson Christopher M. , Cannon Andrew , West Sean , Ghersi Dario , Atri Pranita , Bhatia Rakesh , Smith Lynette , Rachagani Satyayanarayana , Wichman Christopher , Kumar Sushil , Batra Surinder K.
Published: April 2023

PCA reveals significant unique mucin transcriptomic signatures of PDAC tumors
Figure S1 from Mucin Expression and Splicing Determine Novel Subtypes and Patient Mortality in Pancreatic Ductal Adenocarcinoma
Authors: Thompson Christopher M. , Cannon Andrew , West Sean , Ghersi Dario , Atri Pranita , Bhatia Rakesh , Smith Lynette , Rachagani Satyayanarayana , Wichman Christopher , Kumar Sushil , Batra Surinder K.
Published: April 2023

Expression and clustering of mucins in the ICGC PACA-AU PDAC dataset show significant survival differences between mucin signature clusters
Supplementary Figure S1 from A MET Targeting Antibody–Drug Conjugate Overcomes Gemcitabine Resistance in Pancreatic Cancer
Authors: Cazes Alex , Betancourt Oscar , Esparza Edgar , Mose Evangeline S. , Jaquish Dawn , Wong Eric , Wascher Alexis A. , Tiriac Hervé , Gymnopoulos Marco , Lowy Andrew M.
Published: April 2023

MET expression in pancreatic cancer
Supplementary Table from A Phase I Study of an MPS1 Inhibitor (BAY 1217389) in Combination with Paclitaxel Using a Novel Randomized Continual Reassessment Method for Dose Escalation
Authors: Atrafi Florence , Boix Oliver , Subbiah Vivek , Diamond Jennifer R. , Chawla Sant P. , Tolcher Anthony W. , LoRusso Patricia M. , Eder Joseph P. , Gutierrez Martin , Sankhala Kumar , Rajagopalan Prabhu , Genvresse Isabelle , Langer Simon , Mathijssen Ron H.J. , Verweij Jaap , Bruns Ingmar , Lolkema Martijn P.
Published: April 2023

Supplementary Table from A Phase I Study of an MPS1 Inhibitor (BAY 1217389) in Combination with Paclitaxel Using a Novel Randomized Continual Reassessment Method for Dose Escalation
Supplementary Figure from A Phase I Study of an MPS1 Inhibitor (BAY 1217389) in Combination with Paclitaxel Using a Novel Randomized Continual Reassessment Method for Dose Escalation
Authors: Atrafi Florence , Boix Oliver , Subbiah Vivek , Diamond Jennifer R. , Chawla Sant P. , Tolcher Anthony W. , LoRusso Patricia M. , Eder Joseph P. , Gutierrez Martin , Sankhala Kumar , Rajagopalan Prabhu , Genvresse Isabelle , Langer Simon , Mathijssen Ron H.J. , Verweij Jaap , Bruns Ingmar , Lolkema Martijn P.
Published: April 2023

Supplementary Figure from A Phase I Study of an MPS1 Inhibitor (BAY 1217389) in Combination with Paclitaxel Using a Novel Randomized Continual Reassessment Method for Dose Escalation
Supplementary Data from Results from Phase I Extension Study Assessing Pexidartinib Treatment in Six Cohorts with Solid Tumors including TGCT, and Abnormal CSF1 Transcripts in TGCT
Authors: Tap William D. , Singh Arun S. , Anthony Stephen Patrick , Sterba Mike , Zhang Chao , Healey John H. , Chmielowski Bartosz , Cohn Allen Lee , Shapiro Geoffrey I. , Keedy Vicki L. , Wainberg Zev A. , Puzanov Igor , Cote Gregory M. , Wagner Andrew J. , Braiteh Fadi , Sherman Eric , Hsu Henry H. , Peterfy Charles , Gelhorn Heather L. , Ye Xin , Severson Paul , West Brian L. , Lin Paul S. , Tong-Starksen Sandra
Published: April 2023

Supplementary Data from Results from Phase I Extension Study Assessing Pexidartinib Treatment in Six Cohorts with Solid Tumors including TGCT, and Abnormal CSF1 Transcripts in TGCT
Supplementary Data from Multiomic Analysis Reveals Comprehensive Tumor Heterogeneity and Distinct Immune Subtypes in Multifocal Intrahepatic Cholangiocarcinoma
Authors: Chen Shuling , Xie Yubin , Cai Yuhong , Hu Huanjing , He Minghui , Liu Lijuan , Liao Changyi , Wang Yuanqi , Wang Jianping , Ren Xiaoxue , Zeng Qianwen , Peng Hong , Shen Shunli , Li Shaoqiang , Li Dongming , Lai Jiaming , Peng Baogang , Ren Jian , Kuang Ming , Peng Sui
Published: April 2023

Supplementary Data from Multiomic Analysis Reveals Comprehensive Tumor Heterogeneity and Distinct Immune Subtypes in Multifocal Intrahepatic Cholangiocarcinoma
Supplementary Table from The Genomic Landscape of Early-Stage Ovarian High-Grade Serous Carcinoma
Authors: Cheng Zhao , Mirza Hasan , Ennis Darren P. , Smith Philip , Morrill Gavarró Lena , Sokota Chishimba , Giannone Gaia , Goranova Theodora , Bradley Thomas , Piskorz Anna , Lockley Michelle , Kaur Baljeet , Singh Naveena , Tookman Laura A. , Krell Jonathan , McDermott Jacqueline , Macintyre Geoffrey , Markowetz Florian , Brenton James D. , McNeish Iain A.
Published: April 2023

Supplementary Table from The Genomic Landscape of Early-Stage Ovarian High-Grade Serous Carcinoma
Supplementary Figure from The Genomic Landscape of Early-Stage Ovarian High-Grade Serous Carcinoma
Authors: Cheng Zhao , Mirza Hasan , Ennis Darren P. , Smith Philip , Morrill Gavarró Lena , Sokota Chishimba , Giannone Gaia , Goranova Theodora , Bradley Thomas , Piskorz Anna , Lockley Michelle , Kaur Baljeet , Singh Naveena , Tookman Laura A. , Krell Jonathan , McDermott Jacqueline , Macintyre Geoffrey , Markowetz Florian , Brenton James D. , McNeish Iain A.
Published: April 2023

Supplementary Figure from The Genomic Landscape of Early-Stage Ovarian High-Grade Serous Carcinoma
Supplementary Data from Circulating Tumor DNA in Stage III Colorectal Cancer, beyond Minimal Residual Disease Detection, toward Assessment of Adjuvant Therapy Efficacy and Clinical Behavior of Recurrences
Authors: Henriksen Tenna Vesterman , Tarazona Noelia , Frydendahl Amanda , Reinert Thomas , Gimeno-Valiente Francisco , Carbonell-Asins Juan Antonio , Sharma Shruti , Renner Derrick , Hafez Dina , Roda Desamparados , Huerta Marisol , Roselló Susana , Madsen Anders Husted , Løve Uffe S. , Andersen Per Vadgaard , Thorlacius-Ussing Ole , Iversen Lene Hjerrild , Gotschalck Kåre Andersson , Sethi Himanshu , Aleshin Alexey , Cervantes Andres , Andersen Claus Lindbjerg
Published: April 2023

Supplementary Data from Circulating Tumor DNA in Stage III Colorectal Cancer, beyond Minimal Residual Disease Detection, toward Assessment of Adjuvant Therapy Efficacy and Clinical Behavior of Recurrences
Supplementary Figure from First-in-human HER2-targeted Bispecific Antibody KN026 for the Treatment of Patients with HER2-positive Metastatic Breast Cancer: Results from a Phase I Study
Authors: Zhang Jian , Ji Dongmei , Cai Li , Yao Herui , Yan Min , Wang Xiaojia , Shen Weina , Du Yiqun , Pang Hui , Lai Xiuping , Zeng Huiai , Huang Jian , Sun Yan , Peng Xinxin , Xu Junfang , Yang Jing , Yang Fei , Xu Ting , Hu Xichun
Published: April 2023

Supplementary Figure from First-in-human HER2-targeted Bispecific Antibody KN026 for the Treatment of Patients with HER2-positive Metastatic Breast Cancer: Results from a Phase I Study
Supplementary Data from First-in-human HER2-targeted Bispecific Antibody KN026 for the Treatment of Patients with HER2-positive Metastatic Breast Cancer: Results from a Phase I Study
Authors: Zhang Jian , Ji Dongmei , Cai Li , Yao Herui , Yan Min , Wang Xiaojia , Shen Weina , Du Yiqun , Pang Hui , Lai Xiuping , Zeng Huiai , Huang Jian , Sun Yan , Peng Xinxin , Xu Junfang , Yang Jing , Yang Fei , Xu Ting , Hu Xichun
Published: April 2023

Supplementary Data from First-in-human HER2-targeted Bispecific Antibody KN026 for the Treatment of Patients with HER2-positive Metastatic Breast Cancer: Results from a Phase I Study
Supplementary Figure 2 from Integrated Molecular and Immune Phenotype of HER2-Positive Breast Cancer and Response to Neoadjuvant Therapy: A NeoALTTO Exploratory Analysis
Authors: Pizzamiglio Sara , Ciniselli Chiara Maura , Triulzi Tiziana , Gargiuli Chiara , De Cecco Loris , de Azambuja Evandro , Fumagalli Debora , Sotiriou Christos , Harbeck Nadia , Izquierdo Miguel , Nuciforo Paolo , Huober Jens , Cappelletti Vera , Cinieri Saverio , Piccart Martine , Daidone Maria Grazia , Pruneri Giancarlo , Colombo Mario Paolo , Tagliabue Elda , Verderio Paolo , Di Cosimo Serena
Published: April 2023

Supplementary Figure S2. Interaction between immune-related metagenes and treatment arm in the study cohort (n=226; 80 pCR). Red diamond and line indicate Odds Ratio (OR) and its 95% confidence interval (CI) in the combination arm; blue diamond and line indicate OR and its 95% CI in single agent arm (trastuzumab or lapatinib).
Supplementary table from Intralesional SD-101 in Combination with Pembrolizumab in Anti-PD-1 Treatment-Naïve Head and Neck Squamous Cell Carcinoma: Results from a Multicenter, Phase II Trial
Authors: Cohen Ezra E.W. , Nabell Lisle , Wong Deborah J. , Day Terry , Daniels Gregory A. , Milhem Mohammed , Deva Sanjeev , Jameson Michael , Guntinas-Lichius Orlando , Almubarak Mohammed , Strother Matthew , Whitman Eric , Chisamore Michael , Obiozor Cynthia , Bagulho Teresa , Gomez-Romo Jose , Guiducci Cristiana , Janssen Robert , Gamelin Erick , Algazi Alain P.
Published: April 2023

Supplementary table from Intralesional SD-101 in Combination with Pembrolizumab in Anti-PD-1 Treatment-Naïve Head and Neck Squamous Cell Carcinoma: Results from a Multicenter, Phase II Trial
Supplementary Data from Immunogenicity and Safety of COVID-19 Vaccine BNT162b2 for Patients with Solid Cancer: A Large Cohort Prospective Study from a Single Institution
Authors: Di Noia Vincenzo , Pimpinelli Fulvia , Renna Davide , Barberi Vittoria , Maccallini Maria Teresa , Gariazzo Ludovica , Pontone Martina , Monti Alessandro , Campo Flaminia , Taraborelli Emanuela , Di Santo Maria , Petrone Fabrizio , Mandoj Chiara , Ferraresi Virginia , Ferretti Gianluigi , Carlini Paolo , Di Bella Ornella , Conti Laura , La Malfa Antonia Marina , Pellini Raul , Bracco Domenico , Giannarelli Diana , Morrone Aldo , Cognetti Francesco
Published: April 2023

Supplementary Materials
Table S7 from Activation of PI3K/AKT Pathway Is a Potential Mechanism of Treatment Resistance in Small Cell Lung Cancer
Authors: Jin Ying , Chen Yamei , Tang Huarong , Hu Xiao , Hubert Shawna M. , Li Qian , Su Dan , Xu Haimiao , Fan Yun , Yu Xinmin , Chen Qixun , Liu Jinshi , Hong Wei , Xu Yujin , Deng Huan , Zhu Dapeng , Li Pansong , Gong Yuhua , Xia Xuefeng , Gay Carl M. , Zhang Jianjun , Chen Ming
Published: April 2023

Table S7
Immunohistochemistry results and pathologic interpretation for patient No.05, No.06, No.07, No.08 and No.10 whose tumors without combined TP53/RB alterations.
Table S4 from Activation of PI3K/AKT Pathway Is a Potential Mechanism of Treatment Resistance in Small Cell Lung Cancer
Authors: Jin Ying , Chen Yamei , Tang Huarong , Hu Xiao , Hubert Shawna M. , Li Qian , Su Dan , Xu Haimiao , Fan Yun , Yu Xinmin , Chen Qixun , Liu Jinshi , Hong Wei , Xu Yujin , Deng Huan , Zhu Dapeng , Li Pansong , Gong Yuhua , Xia Xuefeng , Gay Carl M. , Zhang Jianjun , Chen Ming
Published: April 2023

Table S4
Primer sequences for verification of 14 PI3K pathway-related genes in-vitro.
Table S15 from Activation of PI3K/AKT Pathway Is a Potential Mechanism of Treatment Resistance in Small Cell Lung Cancer
Authors: Jin Ying , Chen Yamei , Tang Huarong , Hu Xiao , Hubert Shawna M. , Li Qian , Su Dan , Xu Haimiao , Fan Yun , Yu Xinmin , Chen Qixun , Liu Jinshi , Hong Wei , Xu Yujin , Deng Huan , Zhu Dapeng , Li Pansong , Gong Yuhua , Xia Xuefeng , Gay Carl M. , Zhang Jianjun , Chen Ming
Published: April 2023

Table S15
Mutations in H69 cell line.
Table S14 from Activation of PI3K/AKT Pathway Is a Potential Mechanism of Treatment Resistance in Small Cell Lung Cancer
Authors: Jin Ying , Chen Yamei , Tang Huarong , Hu Xiao , Hubert Shawna M. , Li Qian , Su Dan , Xu Haimiao , Fan Yun , Yu Xinmin , Chen Qixun , Liu Jinshi , Hong Wei , Xu Yujin , Deng Huan , Zhu Dapeng , Li Pansong , Gong Yuhua , Xia Xuefeng , Gay Carl M. , Zhang Jianjun , Chen Ming
Published: April 2023

Table S14
SCLC cell lines we selected for differentially expressed pathway analysis.
Supplementary Figure S3 from Development and Validation of Machine Learning–based Model for the Prediction of Malignancy in Multiple Pulmonary Nodules: Analysis from Multicentric Cohorts
Authors: Chen Kezhong , Nie Yuntao , Park Samina , Zhang Kai , Zhang Yangming , Liu Yuan , Hui Bengang , Zhou Lixin , Wang Xun , Qi Qingyi , Li Hao , Kang Guannan , Huang Yuqing , Chen Yingtai , Liu Jiabao , Cui Jian , Li Mingru , Park In Kyu , Kang Chang Hyun , Shen Haifeng , Yang Yingshun , Guan Tian , Zhang Yaxiao , Yang Fan , Kim Young Tae , Wang Jun
Published: April 2023

ROC curves of each center in the prospective comparison cohort
Supplementary Figure S1 from Development and Validation of Machine Learning–based Model for the Prediction of Malignancy in Multiple Pulmonary Nodules: Analysis from Multicentric Cohorts
Authors: Chen Kezhong , Nie Yuntao , Park Samina , Zhang Kai , Zhang Yangming , Liu Yuan , Hui Bengang , Zhou Lixin , Wang Xun , Qi Qingyi , Li Hao , Kang Guannan , Huang Yuqing , Chen Yingtai , Liu Jiabao , Cui Jian , Li Mingru , Park In Kyu , Kang Chang Hyun , Shen Haifeng , Yang Yingshun , Guan Tian , Zhang Yaxiao , Yang Fan , Kim Young Tae , Wang Jun
Published: April 2023

ROC curves of each center in the independent validation cohort
Figure S6 from Activation of PI3K/AKT Pathway Is a Potential Mechanism of Treatment Resistance in Small Cell Lung Cancer
Authors: Jin Ying , Chen Yamei , Tang Huarong , Hu Xiao , Hubert Shawna M. , Li Qian , Su Dan , Xu Haimiao , Fan Yun , Yu Xinmin , Chen Qixun , Liu Jinshi , Hong Wei , Xu Yujin , Deng Huan , Zhu Dapeng , Li Pansong , Gong Yuhua , Xia Xuefeng , Gay Carl M. , Zhang Jianjun , Chen Ming
Published: April 2023

Figure S6
Differentially expressed proteins between the chemo-resistant and chemo-sensitive SCLCs by MS based proteomics. A1, A2, A3 represents chemo-resistant samples; B1, B2, B3 represents chemo-sensitive samples. Genes which have previously been reported to be associated with drug resistance are colored by red. The foldchange: average expression in A group / average expression in B group. MS: mass spectrum.